设为首页 | 加入收藏 | 联系方式 | 站点地图
 
 
教学公告
师资力量
实验室
论文
著作和学术刊物
课程设置
 
 
 
 
您当前的位置:首页 -> 教学信息 -> 教学信息 -> 论文论文
The effectiveness of carbamazepine in unipolar depression: a double-blind, randomized, placebo-controlled study.
作者:佚名   来源:本站整理   发布时间:2010-08-18 09:48:09
 

J Affect Disord. 2008 Jul;109(1-2):91-7. Epub 2008 Feb 21.

The effectiveness of carbamazepine in unipolar depression: a double-blind, randomized, placebo-controlled study.

Zhang ZJ, Tan QR, Tong Y, Li Q, Kang WH, Zhen XC, Post RM.

Department of Psychiatry, Xijing Hospital, The Fourth Military Medical University, Xi'an, Shannxi 710032, China. zhangz68@yahoo.com

Abstract

Our previous studies have shown the effectiveness of carbamazepine (CBZ) in the treatment of bipolar depression. This double-blind, randomized, placebo-controlled study was designed to further evaluate the efficacy of CBZ in unipolar depressed subjects who never received antidepressant and other psychotherapeutic treatment. A total of 89 patients who had at least two major depressive episodes, but never experienced mania or hypomania, were randomly assigned to treatment with immediate-release CBZ 300-800 mg/daily (n=51) or placebo (n=38) for 12 weeks. The primary efficacy was measured using the Hamilton Rating Scale for Depression (HAMD), Montgomery-Asberg Depression Rating Scale (MADRS), and Clinical Global Impression-Severity (CGI-S). The mean final CBZ dose of CBZ-treated patients was 461.6 mg/day. CBZ treatment yielded significantly greater improvements on the three efficacy measures at week 8 through endpoint compared to placebo. Patients assigned to CBZ treatment also had a significantly higher clinical response rate than placebo (74% vs. 42%, p<0.001), as defined for > or = 50% reduction in HAMD score. Based on the results of our present and previous studies, we suggest that CBZ might be considered an alternative in the management of certain conditions in major depressive disorder.

 
 
  医院电话:029-84775507 医院地址:陕西省西安市长乐西路15号
第四军医大学西京医院心身科版权所有,有问题和建议请与我们联系
陕ICP备06008626号